市場調查報告書
商品編碼
1547785
全球醫療外骨骼市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測Global Medical Exoskeleton Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球醫療外骨骼市場需求預計將從 2023 年的 3,724.2 億美元達到近 9,9522.4 億美元的市場規模,2024-2032 年研究期間複合年成長率為 44.06%。
醫用外骨骼是穿戴式機器人設備,旨在幫助行動障礙或殘疾的個人,使他們能夠站立、行走或進行其他日常生活活動。這些設備為使用者的肌肉骨骼系統提供外部支持和幫助,增強他們的力量和活動能力。它通常由佩戴在使用者四肢或軀幹上的輕型可調框架以及檢測和響應用戶運動的馬達、感測器和控制系統組成。它們用於復健環境,透過提供有針對性的物理治療和步態訓練,幫助個人從損傷或神經系統疾病(如脊髓損傷、中風或多發性硬化症)中恢復。
由於神經系統疾病和脊髓損傷的日益流行,醫療外骨骼行業正在經歷顯著成長,這需要先進的復健解決方案。這些設備為患有這些疾病的人提供了增強的移動性和獨立性,顯著提高了他們的生活品質。機器人和穿戴式裝置的技術進步促進了更高效、更輕量和方便用戶使用的外骨骼的開發,使它們更容易為更廣泛的患者群體所使用。此外,隨著老年人尋求行動和日常活動的幫助,全球人口老化也增加了對這些設備的需求。醫療保健專業人員和患者的認知和接受度不斷提高,也推動了該行業的發展。
此外,研發方面的大量投資正在推動創新,從而產生更有效、更實惠的解決方案。醫療機構擴大將外骨骼納入其復健計劃,以改善患者的治療效果並縮短復原時間。監管部門的批准和積極的臨床試驗結果進一步驗證了這些設備的功效和安全性,從而促進了它們的採用。支持先進醫療設備開發和部署的政府舉措和資金也在該行業的成長中發揮著至關重要的作用。隨著技術的不斷發展和其優勢得到更廣泛的認可,該行業已做好持續擴張的準備,為行動障礙提供變革性的解決方案。然而,高昂的成本和有限的可近性可能會阻礙未來幾年醫療外骨骼市場的成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球醫療外骨骼市場的各個細分市場進行了包容性評估。醫療外骨骼產業的成長和趨勢為本研究提供了整體方法。
醫療外骨骼市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲醫療外骨骼市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。醫療外骨骼市場的主要參與者包括Ekso Bionics(美國)、ReWalk(以色列)、Parker Hannifin(美國)、Cyberdyne(日本)和Bionik(加拿大)、Rex Bionics(英國)、B-TEMIA Inc. (加拿大) 、Bioventus(北卡羅來納州)、Hocoma AG(DIH Technologies 子公司)(瑞士)、Wearable Robotics SRL(義大利)、Gogoa Mobility Robots SL(西班牙)、ExoAtlet(盧森堡)、Meditouch(以色列)、Suit X (美國) 、P&S Mechanics(韓國)、Marsi Bionics(西班牙)、Rehab Robotics(香港)、Myomo(美國)。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Medical Exoskeleton Market is presumed to reach the market size of nearly USD 9952.24 Billion by 2032 from USD 372.42 Billion in 2023 with a CAGR of 44.06% under the study period 2024-2032.
Medical exoskeletons are wearable robotic devices designed to assist individuals with mobility impairments or disabilities, enabling them to stand, walk, or perform other activities of daily living. These devices provide external support and assistance to the user's musculoskeletal system, augmenting their strength and mobility. It typically consist of lightweight, adjustable frames worn over the user's limbs or torso, along with motors, sensors, and control systems that detect and respond to the user's movements. They are used in rehabilitation settings to help individuals recover from injuries or neurological conditions, such as spinal cord injury, stroke, or multiple sclerosis, by providing targeted physical therapy and gait training.
The medical exoskeleton industry is witnessing significant growth driven by the increasing prevalence of neurological disorders and spinal cord injuries, which necessitate advanced rehabilitation solutions. These devices offer enhanced mobility and independence to individuals with these conditions, significantly improving their quality of life. Technological advancements in robotics and wearable devices have led to the development of more efficient, lightweight, and user-friendly exoskeletons, making them more accessible to a broader patient base. Additionally, the aging global population is contributing to the demand for these devices as elderly individuals seek assistance with mobility and daily activities. The growing awareness and acceptance among healthcare professionals and patients alike are also propelling the industry forward.
Furthermore, substantial investments in research and development are driving innovation, resulting in more effective and affordable solutions. Healthcare facilities are increasingly incorporating exoskeletons into their rehabilitation programs to enhance patient outcomes and reduce recovery times. Regulatory approvals and positive clinical trial results are further validating the efficacy and safety of these devices, boosting their adoption. Government initiatives and funding to support the development and deployment of advanced medical devices are also playing a crucial role in the industry's growth. As the technology continues to evolve and the benefits become more widely recognized, the industry is poised for sustained expansion, offering transformative solutions for mobility impairments. However, high costs and limited accessibility may hinder the medical exoskeleton market growth in the next few years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain Analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Medical Exoskeleton. The growth and trends of Medical Exoskeleton industry provide a holistic approach to this study.
This section of the Medical Exoskeleton market report provides detailed data on the segments at the country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Medical Exoskeleton market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Exoskeleton market include Ekso Bionics (US), ReWalk (Israel), Parker Hannifin (US), Cyberdyne (Japan) And Bionik (Canada), Rex Bionics (UK), B-TEMIA Inc. (Canada), Bioventus (North Carolina), Hocoma AG (A Subsidiary Of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), ExoAtlet (Luxembourg), Meditouch (Israel), Suit X (US), P&S Mechanics (South Korea), Marsi Bionics (Spain), Rehab Robotics (Hong Kong), Myomo (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.